Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1996 Dec;64(12):5171–5177. doi: 10.1128/iai.64.12.5171-5177.1996

A 35-kilodalton protein is a major target of the human immune response to Mycobacterium leprae.

J A Triccas 1, P W Roche 1, N Winter 1, C G Feng 1, C R Butlin 1, W J Britton 1
PMCID: PMC174504  PMID: 8945562

Abstract

The control of leprosy will be facilitated by the identification of major Mycobacterium leprae-specific antigens which mirror the immune response to the organism across the leprosy spectrum. We have investigated the host response to a 35-kDa protein of M. leprae. Recombinant 35-kDa protein purified from Mycobacterium smegmatis resembled the native antigen in the formation of multimeric complexes and binding by monoclonal antibodies and sera from leprosy patients. These properties were not shared by two forms of 35-kDa protein purified from Escherichia coli. The M. smegmatis-derived 35-kDa protein stimulated a gamma interferon-secreting T-cell proliferative response in the majority of paucibacillary leprosy patients and healthy contacts of leprosy patients tested. Cellular responses to the protein in patients with multibacillary leprosy were weak or absent, consistent with hyporesponsiveness to M. leprae characteristic of this form of the disease. Almost all leprosy patients and contacts recognized the 35-kDa protein by either a T-cell proliferative or an immunoglobulin G antibody response, whereas few tuberculosis patients recognized the antigen. This specificity was confirmed in guinea pigs, with the 35-kDa protein eliciting strong delayed-type hypersensitivity in M. leprae-sensitized animals but not in those sensitized with Mycobacterium tuberculosis or Mycobacterium bovis BCG. Therefore, the M. leprae 35-kDa protein appears to be a major and relatively specific target of the human immune response to M. leprae and is a potential component of a diagnostic test to detect exposure to leprosy or a vaccine to combat the disease.

Full Text

The Full Text of this article is available as a PDF (275.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams E., Britton W., Morgan A., Sergeantson S., Basten A. Individuals from different populations identify multiple and diverse T-cell determinants on mycobacterial HSP70. Scand J Immunol. 1994 Jun;39(6):588–596. doi: 10.1111/j.1365-3083.1994.tb03417.x. [DOI] [PubMed] [Google Scholar]
  2. Bloom B. R., Modlin R. L., Salgame P. Stigma variations: observations on suppressor T cells and leprosy. Annu Rev Immunol. 1992;10:453–488. doi: 10.1146/annurev.iy.10.040192.002321. [DOI] [PubMed] [Google Scholar]
  3. Bretscher P. A. A strategy to improve the efficacy of vaccination against tuberculosis and leprosy. Immunol Today. 1992 Sep;13(9):342–345. doi: 10.1016/0167-5699(92)90168-7. [DOI] [PubMed] [Google Scholar]
  4. Britton W. J., Hellqvist L., Basten A., Inglis A. S. Immunoreactivity of a 70 kD protein purified from Mycobacterium bovis Bacillus Calmette-Guerin by monoclonal antibody affinity chromatography. J Exp Med. 1986 Sep 1;164(3):695–708. doi: 10.1084/jem.164.3.695. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Britton W. J., Hellqvist L., Basten A., Raison R. L. Mycobacterium leprae antigens involved in human immune responses. I. Identification of four antigens by monoclonal antibodies. J Immunol. 1985 Dec;135(6):4171–4177. [PubMed] [Google Scholar]
  6. Britton W. J., Hellqvist L., Garsia R. J., Basten A. Dominant cell wall proteins of Mycobacterium leprae recognized by monoclonal antibodies. Clin Exp Immunol. 1987 Jan;67(1):31–42. [PMC free article] [PubMed] [Google Scholar]
  7. Britton W. J., Hellqvist L., Ivanyi J., Basten A. Immunopurification of radiolabelled antigens of Mycobacterium leprae and Mycobacterium bovis (bacillus Calmette-Guerin) with monoclonal antibodies. Scand J Immunol. 1987 Aug;26(2):149–159. doi: 10.1111/j.1365-3083.1987.tb02247.x. [DOI] [PubMed] [Google Scholar]
  8. Britton W. J. Immunology of leprosy. Trans R Soc Trop Med Hyg. 1993 Sep-Oct;87(5):508–514. doi: 10.1016/0035-9203(93)90066-y. [DOI] [PubMed] [Google Scholar]
  9. Cooper A. M., Dalton D. K., Stewart T. A., Griffin J. P., Russell D. G., Orme I. M. Disseminated tuberculosis in interferon gamma gene-disrupted mice. J Exp Med. 1993 Dec 1;178(6):2243–2247. doi: 10.1084/jem.178.6.2243. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Flynn J. L., Chan J., Triebold K. J., Dalton D. K., Stewart T. A., Bloom B. R. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med. 1993 Dec 1;178(6):2249–2254. doi: 10.1084/jem.178.6.2249. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hunter S. W., Rivoire B., Mehra V., Bloom B. R., Brennan P. J. The major native proteins of the leprosy bacillus. J Biol Chem. 1990 Aug 25;265(24):14065–14068. [PubMed] [Google Scholar]
  12. Ivanyi J., Sinha S., Aston R., Cussell D., Keen M., Sengupta U. Definition of species specific and cross-reactive antigenic determinants of Mycobacterium leprae using monoclonal antibodies. Clin Exp Immunol. 1983 Jun;52(3):528–536. [PMC free article] [PubMed] [Google Scholar]
  13. Kaleab B., Wondimu A., Likassa R., Woldehawariat N., Ivanyi J. Sustained T-cell reactivity to Mycobacterium tuberculosis specific antigens in 'split-anergic' leprosy. Lepr Rev. 1995 Mar;66(1):19–25. [PubMed] [Google Scholar]
  14. Launois P., N'Diaye M. N., Cartel J. L., Mane I., Drowart A., Van Vooren J. P., Sarthou J. L., Huygen K. Fibronectin-binding antigen 85 and the 10-kilodalton GroES-related heat shock protein are the predominant TH-1 response inducers in leprosy contacts. Infect Immun. 1995 Jan;63(1):88–93. doi: 10.1128/iai.63.1.88-93.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Launois P., Niang M. N., Sarthou J. L., Rivier F., Drowart A., Van Vooren J. P., Millan J., Huygen K. T-cell stimulation with purified mycobacterial antigens in patients and healthy subjects infected with Mycobacterium leprae: secreted antigen 85 is another immunodominant antigen. Scand J Immunol. 1993 Aug;38(2):167–176. doi: 10.1111/j.1365-3083.1993.tb01709.x. [DOI] [PubMed] [Google Scholar]
  16. McKenzie K. R., Adams E., Britton W. J., Garsia R. J., Basten A. Sequence and immunogenicity of the 70-kDa heat shock protein of Mycobacterium leprae. J Immunol. 1991 Jul 1;147(1):312–319. [PubMed] [Google Scholar]
  17. Mehra V., Bloom B. R., Bajardi A. C., Grisso C. L., Sieling P. A., Alland D., Convit J., Fan X. D., Hunter S. W., Brennan P. J. A major T cell antigen of Mycobacterium leprae is a 10-kD heat-shock cognate protein. J Exp Med. 1992 Jan 1;175(1):275–284. doi: 10.1084/jem.175.1.275. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Mohagheghpour N., Munn M. W., Gelber R. H., Engleman E. G. Identification of an immunostimulating protein from Mycobacterium leprae. Infect Immun. 1990 Mar;58(3):703–710. doi: 10.1128/iai.58.3.703-710.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Mwatha J., Moreno C., Sengupta U., Sinha S., Ivanyi J. A comparative evaluation of serological assays for lepromatous leprosy. Lepr Rev. 1988 Sep;59(3):195–199. doi: 10.5935/0305-7518.19880024. [DOI] [PubMed] [Google Scholar]
  20. Ottenhoff T. H., Converse P. J., Gebre N., Wondimu A., Ehrenberg J. P., Kiessling R. T cell responses to fractionated Mycobacterium leprae antigens in leprosy. The lepromatous nonresponder defect can be overcome in vitro by stimulation with fractionated M. leprae components. Eur J Immunol. 1989 Apr;19(4):707–713. doi: 10.1002/eji.1830190421. [DOI] [PubMed] [Google Scholar]
  21. Ottenhoff T. H., Wondimu A., Reddy N. N. A comparative study on the effects of rIL-4, rIL-2, rIFN-gamma, and rTNF-alpha on specific T-cell non-responsiveness to mycobacterial antigens in lepromatous leprosy patients in vitro. Scand J Immunol. 1990 May;31(5):553–565. doi: 10.1111/j.1365-3083.1990.tb02806.x. [DOI] [PubMed] [Google Scholar]
  22. Parkash O., Chaturvedi V., Girdhar B. K., Sengupta U. A study on performance of two serological assays for diagnosis of leprosy patients. Lepr Rev. 1995 Mar;66(1):26–30. doi: 10.5935/0305-7518.19950004. [DOI] [PubMed] [Google Scholar]
  23. Ridley D. S., Jopling W. H. Classification of leprosy according to immunity. A five-group system. Int J Lepr Other Mycobact Dis. 1966 Jul-Sep;34(3):255–273. [PubMed] [Google Scholar]
  24. Roche P. W., Britton W. J., Failbus S. S., Neupane K. D., Theuvenet W. J. Serological monitoring of the response to chemotherapy in leprosy patients. Int J Lepr Other Mycobact Dis. 1993 Mar;61(1):35–43. [PubMed] [Google Scholar]
  25. Roche P. W., Britton W. J., Failbus S. S., Williams D., Pradhan H. M., Theuvenet W. J. Operational value of serological measurements in multibacillary leprosy patients: clinical and bacteriological correlates of antibody responses. Int J Lepr Other Mycobact Dis. 1990 Sep;58(3):480–490. [PubMed] [Google Scholar]
  26. Roche P. W., Peake P. W., Billman-Jacobe H., Doran T., Britton W. J. T-cell determinants and antibody binding sites on the major mycobacterial secretory protein MPB59 of Mycobacterium bovis. Infect Immun. 1994 Dec;62(12):5319–5326. doi: 10.1128/iai.62.12.5319-5326.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Roche P. W., Winter N., Triccas J. A., Feng C. G., Britton W. J. Expression of Mycobacterium tuberculosis MPT64 in recombinant Myco. smegmatis: purification, immunogenicity and application to skin tests for tuberculosis. Clin Exp Immunol. 1996 Feb;103(2):226–232. doi: 10.1046/j.1365-2249.1996.d01-613.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Salgame P., Abrams J. S., Clayberger C., Goldstein H., Convit J., Modlin R. L., Bloom B. R. Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science. 1991 Oct 11;254(5029):279–282. doi: 10.1126/science.254.5029.279. [DOI] [PubMed] [Google Scholar]
  29. Sela S., Thole J. E., Ottenhoff T. H., Clark-Curtiss J. E. Identification of Mycobacterium leprae antigens from a cosmid library: characterization of a 15-kilodalton antigen that is recognized by both the humoral and cellular immune systems in leprosy patients. Infect Immun. 1991 Nov;59(11):4117–4124. doi: 10.1128/iai.59.11.4117-4124.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Sinha S., Sengupta U., Ramu G., Ivanyi J. A serological test for leprosy based on competitive inhibition of monoclonal antibody binding to the MY2a determinant of Mycobacterium leprae. Trans R Soc Trop Med Hyg. 1983;77(6):869–871. doi: 10.1016/0035-9203(83)90309-7. [DOI] [PubMed] [Google Scholar]
  31. Sinha S., Sengupta U., Ramu G., Ivanyi J. Serological survey of leprosy and control subjects by a monoclonal antibody-based immunoassay. Int J Lepr Other Mycobact Dis. 1985 Mar;53(1):33–38. [PubMed] [Google Scholar]
  32. Timm J., Perilli M. G., Duez C., Trias J., Orefici G., Fattorini L., Amicosante G., Oratore A., Joris B., Frère J. M. Transcription and expression analysis, using lacZ and phoA gene fusions, of Mycobacterium fortuitum beta-lactamase genes cloned from a natural isolate and a high-level beta-lactamase producer. Mol Microbiol. 1994 May;12(3):491–504. doi: 10.1111/j.1365-2958.1994.tb01037.x. [DOI] [PubMed] [Google Scholar]
  33. Wiker H. G., Harboe M. The antigen 85 complex: a major secretion product of Mycobacterium tuberculosis. Microbiol Rev. 1992 Dec;56(4):648–661. doi: 10.1128/mr.56.4.648-661.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Winter N., Triccas J. A., Rivoire B., Pessolani M. C., Eiglmeier K., Lim E. M., Hunter S. W., Brennan P. J., Britton W. J. Characterization of the gene encoding the immunodominant 35 kDa protein of Mycobacterium leprae. Mol Microbiol. 1995 Jun;16(5):865–876. doi: 10.1111/j.1365-2958.1995.tb02314.x. [DOI] [PubMed] [Google Scholar]
  35. Yamamura M., Uyemura K., Deans R. J., Weinberg K., Rea T. H., Bloom B. R., Modlin R. L. Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science. 1991 Oct 11;254(5029):277–279. doi: 10.1126/science.254.5029.277. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES